$CDLX
Cardlytics, Inc. Stock $cdlx

$cdlx Overview Financials Valuation SEC Filings Company Website

2020 Q2 Form 10-Q Financial Statement

#000166607120000232 Filed on August 04, 2020

Income Statement

Concept	2020 Q2	2019 Q2	2019 Q1
Revenue	$28.22M	$48.73M	$35.99M
YoY Change	-42.08%	37.0%	10.01%
Cost Of Revenue	$16.81M	$27.62M	$19.00M
YoY Change	-39.14%	39.85%	-11.3%
Gross Profit	$11.41M	$21.11M	$16.98M
YoY Change	-45.95%	33.44%	50.4%
Gross Profit Margin	40.43%	43.32%	47.18%
Selling, General & Admin	$22.14M	$19.39M	$16.34M
YoY Change	14.2%	0.84%	10.4%
% of Gross Profit	194.03%	91.84%	96.21%
Research & Development	$3.966M	$2.782M	$2.941M
YoY Change	42.56%	-43.09%	-14.98%
% of Gross Profit	34.76%	13.18%	17.32%
Depreciation & Amortization	$1.550M	$1.050M	$961.0K
YoY Change	47.62%	34.62%	5.6%
% of Gross Profit	13.58%	4.97%	5.66%
Operating Expenses	$26.11M	$22.17M	$19.28M
YoY Change	17.75%	-8.07%	5.59%
Operating Profit	-$19.74M	-$5.482M	-$6.501M
YoY Change	260.05%	-52.88%	-33.78%
Interest Expense	-$20.00K	-$340.0K	-$300.0K
YoY Change	-94.12%	-154.84%	-97.25%
% of Operating Profit
Other Income/Expense, Net	-$20.00K	-$1.028M	$187.0K
YoY Change	-98.05%	-27.55%	-101.83%
Pretax Income	-$19.76M	-$6.510M	-$6.314M
YoY Change	203.5%	-50.13%	-68.52%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$19.76M	-$6.510M	-$6.314M
YoY Change	203.5%	-50.13%	-68.52%
Net Earnings / Revenue	-70.01%	-13.36%	-17.54%
Basic Earnings Per Share
Diluted Earnings Per Share	-$730.0K	-$286.4K	-$280.4K
COMMON SHARES
Basic Shares Outstanding	26.97M shares	22.57M shares	22.50M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2020 Q2	2019 Q2	2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$98.40M	$32.50M	$36.40M
YoY Change	202.77%	-35.64%	-59.47%
Cash & Equivalents	$98.37M	$32.50M	$36.43M
Short-Term Investments
Other Short-Term Assets	$6.500M	$15.90M	$25.30M
YoY Change	-59.12%	-32.05%	583.78%
Inventory
Prepaid Expenses
Receivables	$36.57M	$63.77M	$53.25M
Other Receivables	$5.007M	$3.171M	$2.328M
Total Short-Term Assets	$146.4M	$115.3M	$117.3M
YoY Change	26.98%	-1.84%	-13.81%
LONG-TERM ASSETS
Property, Plant & Equipment	$12.98M	$11.90M	$11.35M
YoY Change	9.15%	51.94%	54.16%
Goodwill
YoY Change
Intangibles	$407.0K	$369.0K	$367.0K
YoY Change	10.3%	0.82%	2.23%
Long-Term Investments
YoY Change
Other Assets	$1.701M	$1.281M	$1.369M
YoY Change	32.79%	16.77%	38.56%
Total Long-Term Assets	$36.64M	$28.26M	$29.17M
YoY Change	29.66%	24.0%	34.36%
TOTAL ASSETS
Total Short-Term Assets	$146.4M	$115.3M	$117.3M
Total Long-Term Assets	$36.64M	$28.26M	$29.17M
Total Assets	$183.0M	$143.6M	$146.5M
YoY Change	27.5%	2.36%	-7.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.177M	$1.212M	$1.896M
YoY Change	-2.89%	32.03%	6.34%
Accrued Expenses	$3.270M	$4.012M	$3.743M
YoY Change	-18.49%	-11.04%	-4.47%
Deferred Revenue	$969.0K	$397.0K	$574.0K
YoY Change	144.08%	128.16%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Long-Term Debt Due	$24.00K	$22.00K	$22.00K
YoY Change	9.09%	0.0%	-99.91%
Total Short-Term Liabilities	$42.46M	$57.42M	$49.56M
YoY Change	-26.06%	9.28%	-38.67%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$36.68M	$46.69M
YoY Change	-100.0%	-22.77%	41.94%
Other Long-Term Liabilities	$10.10M
YoY Change
Total Long-Term Liabilities	$0.00	$97.02M	$99.29M
YoY Change	-100.0%	90.48%	172.42%
TOTAL LIABILITIES
Total Short-Term Liabilities	$42.46M	$57.42M	$49.56M
Total Long-Term Liabilities	$0.00	$97.02M	$99.29M
Total Liabilities	$52.57M	$154.4M	$148.8M
YoY Change	-65.96%	49.25%	26.95%
SHAREHOLDERS EQUITY
Retained Earnings	-$371.9M	-$334.3M	-$327.8M
YoY Change	11.25%	10.86%	13.62%
Common Stock	$499.7M	$378.8M	$373.4M
YoY Change	31.92%	12.44%	13.66%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$130.5M	$46.54M	$47.18M
YoY Change
Total Liabilities & Shareholders Equity	$183.0M	$143.6M	$146.5M
YoY Change	27.5%	2.36%	-7.19%

Cashflow Statement

Concept	2020 Q2	2019 Q2	2019 Q1
OPERATING ACTIVITIES
Net Income	-$19.76M	-$6.510M	-$6.314M
YoY Change	203.5%	-50.13%	-68.52%
Depreciation, Depletion And Amortization	$1.550M	$1.050M	$961.0K
YoY Change	47.62%	34.62%	5.6%
Cash From Operating Activities	-$4.230M	-$1.490M	-$1.483M
YoY Change	183.89%	-88.27%	1547.78%
INVESTING ACTIVITIES
Capital Expenditures	-$1.950M	-$3.180M	$1.492M
YoY Change	-38.68%	132.12%	256.94%
Acquisitions	$0.00
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$1.950M	-$3.180M	-$1.981M
YoY Change	-38.68%	132.12%	149.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$173.0K
YoY Change			-99.75%
Debt Paid & Issued, Net			$5.000K
YoY Change			-80.77%
Cash From Financing Activities	2.270M	-9.050M	$162.0K
YoY Change	-125.08%	80.28%	-99.77%
NET CHANGE
Cash From Operating Activities	-4.230M	-1.490M	-$1.483M
Cash From Investing Activities	-1.950M	-3.180M	-$1.981M
Cash From Financing Activities	2.270M	-9.050M	$162.0K
Net Change In Cash	-3.910M	-13.72M	-$3.182M
YoY Change	-71.5%	-28.13%	-104.64%
FREE CASH FLOW
Cash From Operating Activities	-$4.230M	-$1.490M	-$1.483M
Capital Expenditures	-$1.950M	-$3.180M	$1.492M
Free Cash Flow	-$2.280M	$1.690M	-$2.975M
YoY Change	-234.91%	-114.92%	485.63%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
	dei	Entity Central Index Key EntityCentralIndexKey	0001666071
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2020Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	22466000	shares
CY2020Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	25664000	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	22466000	shares
CY2020Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	25664000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P4Y
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2020-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-38386
	dei	Entity Registrant Name EntityRegistrantName	CARDLYTICS, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-3039436
	dei	Entity Address Address Line1 EntityAddressAddressLine1	675 Ponce de Leon Ave. NE, Ste 6000
	dei	Entity Address City Or Town EntityAddressCityOrTown	Atlanta
	dei	Entity Address State Or Province EntityAddressStateOrProvince	GA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	30308
	dei	City Area Code CityAreaCode	(888)
	dei	Local Phone Number LocalPhoneNumber	792-5802
	dei	Security12b Title Security12bTitle	Common Stock
	dei	Trading Symbol TradingSymbol	CDLX
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2020Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	27286104	shares
CY2020Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	104458000	USD
CY2020Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	98370000	USD
CY2019Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	129000	USD
CY2020Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	36566000	USD
CY2020Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	105000	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	81452000	USD
CY2019Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	3908000	USD
CY2020Q2	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	5007000	USD
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5783000	USD
CY2020Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6356000	USD
CY2019Q4	us-gaap	Assets Current AssetsCurrent	195730000	USD
CY2020Q2	us-gaap	Assets Current AssetsCurrent	146404000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	14290000	USD
CY2020Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12983000	USD
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	0	USD
CY2020Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	10422000	USD
CY2019Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	389000	USD
CY2020Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	407000	USD
CY2019Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	3815000	USD
CY2020Q2	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	4738000	USD
CY2019Q4	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	8383000	USD
CY2020Q2	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	6384000	USD
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1706000	USD
CY2020Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1701000	USD
CY2019Q4	us-gaap	Assets Assets	224313000	USD
CY2020Q2	us-gaap	Assets Assets	183039000	USD
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1229000	USD
CY2020Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1177000	USD
CY2019Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	8186000	USD
CY2020Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4904000	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6018000	USD
CY2020Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3270000	USD
CY2019Q4	cdlx	Financial Institution Share Liability Current FinancialInstitutionShareLiabilityCurrent	41956000	USD
CY2020Q2	cdlx	Financial Institution Share Liability Current FinancialInstitutionShareLiabilityCurrent	19291000	USD
CY2019Q4	cdlx	Customer Incentive Liability CustomerIncentiveLiability	19861000	USD
CY2020Q2	cdlx	Customer Incentive Liability CustomerIncentiveLiability	9113000	USD
CY2019Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1127000	USD
CY2020Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	969000	USD
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	0	USD
CY2020Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3712000	USD
CY2019Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	24000	USD
CY2020Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	24000	USD
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	78401000	USD
CY2020Q2	us-gaap	Liabilities Current LiabilitiesCurrent	42460000	USD
CY2020Q2	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	0	USD
CY2019Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	2632000	USD
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	USD
CY2020Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	10114000	USD
CY2019Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	13000	USD
CY2020Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	0	USD
CY2019Q4	us-gaap	Liabilities Liabilities	81046000	USD
CY2020Q2	us-gaap	Liabilities Liabilities	52574000	USD
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	8000	USD
CY2020Q2	us-gaap	Common Stock Value CommonStockValue	8000	USD
CY2019Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	480578000	USD
CY2020Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	499663000	USD
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1312000	USD
CY2020Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2714000	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-338631000	USD
CY2020Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-371920000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	143267000	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	130465000	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	224313000	USD
CY2020Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	183039000	USD
CY2019Q2	us-gaap	Revenues Revenues	48730000	USD
CY2020Q2	us-gaap	Revenues Revenues	28222000	USD
	us-gaap	Revenues Revenues	84718000	USD
	us-gaap	Revenues Revenues	73731000	USD
CY2019Q2	cdlx	Financial Institution Share And Other Third Party Costs FinancialInstitutionShareAndOtherThirdPartyCosts	27620000	USD
CY2020Q2	cdlx	Financial Institution Share And Other Third Party Costs FinancialInstitutionShareAndOtherThirdPartyCosts	16811000	USD
	cdlx	Financial Institution Share And Other Third Party Costs FinancialInstitutionShareAndOtherThirdPartyCosts	46624000	USD
	cdlx	Financial Institution Share And Other Third Party Costs FinancialInstitutionShareAndOtherThirdPartyCosts	42949000	USD
CY2019Q2	cdlx	Delivery Costs DeliveryCosts	3370000	USD
CY2020Q2	cdlx	Delivery Costs DeliveryCosts	3499000	USD
	cdlx	Delivery Costs DeliveryCosts	6616000	USD
	cdlx	Delivery Costs DeliveryCosts	6905000	USD
CY2019Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	11047000	USD
CY2020Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	10405000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	20384000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	21373000	USD
CY2019Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2782000	USD
CY2020Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3966000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5723000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7817000	USD
CY2019Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8340000	USD
CY2020Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11734000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	15340000	USD
CY2019Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1053000	USD
CY2020Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1545000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	22478000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2014000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3876000	USD
CY2019Q2	us-gaap	Costs And Expenses CostsAndExpenses	54212000	USD
CY2020Q2	us-gaap	Costs And Expenses CostsAndExpenses	47960000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	96701000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	105398000	USD
CY2019Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-5482000	USD
CY2020Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-19738000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-11983000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-31667000	USD
CY2019Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-338000	USD
CY2020Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-10000	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-642000	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	274000	USD
CY2019Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-690000	USD
CY2020Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-10000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-199000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1896000	USD
CY2019Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1028000	USD
CY2020Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-20000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-841000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1622000	USD
CY2019Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6510000	USD
CY2020Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-19758000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-12824000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-33289000	USD
CY2020Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	-6510000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-19758000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-12824000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-33289000	USD
CY2019Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-6510000	USD
CY2020Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-19758000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-12824000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-33289000	USD
CY2019Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.29
CY2020Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.73
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.57
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.24
CY2019Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1165000	USD
CY2019Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	22731000	shares
CY2020Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	27072000	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	22618000	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	26898000	shares
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	-6510000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-19758000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-12824000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-33289000	USD
CY2019Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	449000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	105000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	77000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	1402000	USD
CY2019Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-6061000	USD
CY2020Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-19653000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-12747000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-31887000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	143267000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	5426000	USD
	cdlx	Stock Issued During Period Shares Warrants Exercised In Period StockIssuedDuringPeriodSharesWarrantsExercisedInPeriod	0	shares
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	12347000	USD
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1312000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	1402000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-33289000	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	130465000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	138358000	USD
CY2020Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2281000	USD
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	8167000	USD
CY2020Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1312000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	105000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-19758000	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	130465000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	51975000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1348000	USD
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	4797000	USD
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1165000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	77000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-12824000	USD
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	46538000	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	47177000	USD
CY2019Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1175000	USD
CY2019Q2	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	3082000	USD
CY2019Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	449000	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	-6510000	USD
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	46538000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-12824000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-33289000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	652000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1326000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2014000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3876000	USD
	cdlx	Capitalized Contract Cost Amortization Interest Expense CapitalizedContractCostAmortizationInterestExpense	50000	USD
	cdlx	Capitalized Contract Cost Amortization Interest Expense CapitalizedContractCostAmortizationInterestExpense	48000	USD
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	0	USD
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	1731000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	4780000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	13233000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-351000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-2073000	USD
	cdlx	Contractwith Customer Asset Deferred Implementation Costs Amortization ContractwithCustomerAssetDeferredImplementationCostsAmortization	1384000	USD
	cdlx	Contractwith Customer Asset Deferred Implementation Costs Amortization ContractwithCustomerAssetDeferredImplementationCostsAmortization	1999000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	7024000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-42460000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1622000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	603000	USD
	cdlx	Contractwith Customer Asset Deferred Financial Institution Implementation Costs Recoveries Through Financial Institution Share Net ContractwithCustomerAssetDeferredFinancialInstitutionImplementationCostsRecoveriesThroughFinancialInstitutionShareNet	2312000	USD
	cdlx	Contractwith Customer Asset Deferred Financial Institution Implementation Costs Recoveries Through Financial Institution Share Net ContractwithCustomerAssetDeferredFinancialInstitutionImplementationCostsRecoveriesThroughFinancialInstitutionShareNet	0	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-306000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-163000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	323000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-6922000	USD
	cdlx	Increase Decrease In Financial Institution Share Liability IncreaseDecreaseInFinancialInstitutionShareLiability	2932000	USD
	cdlx	Increase Decrease In Financial Institution Share Liability IncreaseDecreaseInFinancialInstitutionShareLiability	-22665000	USD
	cdlx	Increase Decrease In Consumer Incentive Liability IncreaseDecreaseInConsumerIncentiveLiability	4009000	USD
	cdlx	Increase Decrease In Consumer Incentive Liability IncreaseDecreaseInConsumerIncentiveLiability	-10748000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2969000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7644000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4019000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1225000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	5000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	30000	USD
	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	1139000	USD
	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	2132000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5163000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3387000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	10010000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	11000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1213000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	5435000	USD
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	93000	USD
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	13000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-8890000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5411000	USD
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-99000	USD
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-492000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-17121000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-6112000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	59870000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	104587000	USD
CY2019Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	42749000	USD
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	98475000	USD
CY2019Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	32495000	USD
CY2020Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	98370000	USD
CY2019Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	10254000	USD
CY2020Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	105000	USD
CY2019Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	42749000	USD
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	98475000	USD
	us-gaap	Interest Paid InterestPaid	771000	USD
	us-gaap	Interest Paid InterestPaid	32000	USD
CY2019Q2	cdlx	Property And Equipment Incurred But Not Yet Paid PropertyAndEquipmentIncurredButNotYetPaid	53000	USD
CY2020Q2	cdlx	Property And Equipment Incurred But Not Yet Paid PropertyAndEquipmentIncurredButNotYetPaid	452000	USD
	us-gaap	Use Of Estimates UseOfEstimates	<div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</span></div><div style="line-height:120%;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements. Significant items subject to such estimates and assumptions include revenue recognition, internal-use software development costs, income taxes, stock-based compensation, allowance for doubtful accounts, income tax valuation allowance and contingencies. We base our estimates on historical experience and on assumptions that we believe are reasonable. Changes in facts or circumstances may cause us to change our assumptions and estimates in future periods and it is possible that actual results could differ from our current or revised future estimates.</span></div>
CY2020Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	800000	USD
CY2020Q2	us-gaap	Restructuring Charges RestructuringCharges	400000	USD
	us-gaap	Restructuring Charges RestructuringCharges	900000	USD
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	1200000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1300000	USD
CY2019Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	397000	USD
CY2020Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1383000	USD
CY2018Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	169000	USD
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	255000	USD
CY2019Q2	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	402000	USD
CY2020Q2	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	151000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	652000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1326000	USD
CY2019Q2	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	227000	USD
CY2020Q2	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	212000	USD
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	249000	USD
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	561000	USD
CY2019Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	572000	USD
CY2020Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1020000	USD
CY2019Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	572000	USD
CY2020Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1020000	USD
CY2020Q2	cdlx	Lease Weighted Average Discount Rate Percent LeaseWeightedAverageDiscountRatePercent	0.034
	cdlx	Lease Weighted Average Remaining Lease Term LeaseWeightedAverageRemainingLeaseTerm	P3Y9M21D
	us-gaap	Variable Lease Cost VariableLeaseCost	472000	USD
CY2020Q2	us-gaap	Short Term Lease Cost ShortTermLeaseCost	45000	USD
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	157000	USD
CY2019Q2	cdlx	Consumer Incentives Expense ConsumerIncentivesExpense	25000000.0	USD
CY2020Q2	cdlx	Consumer Incentives Expense ConsumerIncentivesExpense	11300000	USD
	cdlx	Consumer Incentives Expense ConsumerIncentivesExpense	47600000	USD
	cdlx	Consumer Incentives Expense ConsumerIncentivesExpense	33600000	USD
CY2019Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	48730000	USD
CY2020Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	28222000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	84718000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	73731000	USD
	cdlx	Operating Lease Modification OperatingLeaseModification	2100000	USD
CY2020Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	886000	USD
	us-gaap	Operating Lease Expense OperatingLeaseExpense	1913000	USD
CY2020Q2	us-gaap	Variable Lease Cost VariableLeaseCost	175000	USD
CY2020Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	2098000	USD
CY2020Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	3969000	USD
CY2020Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	3932000	USD
CY2020Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	2348000	USD
CY2020Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	1807000	USD
CY2020Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	611000	USD
CY2020Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	14765000	USD
CY2020Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	939000	USD
CY2020Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	13826000	USD
CY2020Q2	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	3040000	USD
CY2020Q2	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	2759000	USD
CY2020Q2	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	2808000	USD
CY2020Q2	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	1847000	USD
CY2020Q2	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	1807000	USD
CY2020Q2	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	611000	USD
CY2020Q2	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	12872000	USD
CY2020Q2	us-gaap	Debt Instrument Unused Borrowing Capacity Amount DebtInstrumentUnusedBorrowingCapacityAmount	26400000	USD
CY2020Q2	cdlx	Line Of Credit Facility Maximum Borrowing Capacity Percentage Of Eligible Accounts Receivable LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleAccountsReceivable	0.85
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	1875000	shares
CY2018Q1	cdlx	Sharebased Compensation Arrangementby Sharebased Payment Award Numberof Shares Remaining For Available For Issuance SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofSharesRemainingForAvailableForIssuance	61247	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	1345631	shares
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized	1327352	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	1400000	USD
CY2019Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3072000	USD
CY2020Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	9108000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4780000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	13233000	USD
	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	100000	USD
	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	200000	USD
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P10Y
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1000000	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	22.99
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	275000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	19.71
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	9000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	28.71
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	1000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	28.96
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	715000	shares
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	24.17
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	32752000	USD
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	607000	shares
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	23.87
CY2020Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	27983000	USD
	cdlx	Sharebased Compensation Arrangementby Sharebased Payment Award Monthly Average Closing Price Common Stock Threshold SharebasedCompensationArrangementbySharebasedPaymentAwardMonthlyAverageClosingPriceCommonStockThreshold	69.98
CY2020Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	1300000	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	15200000	USD
	cdlx	Classof Warrantor Right Exercised ClassofWarrantorRightExercised	644365	shares
CY2019Q1	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	14067000	USD
CY2020Q1	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	7375000	USD
CY2018Q4	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	15877000	USD
CY2019Q4	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	8383000	USD
CY2019Q2	cdlx	Contractwith Customer Asset Deferred Financial Institution Implementation Costs Recoveries Through Financial Institution Share Net ContractwithCustomerAssetDeferredFinancialInstitutionImplementationCostsRecoveriesThroughFinancialInstitutionShareNet	1155000	USD
CY2020Q2	cdlx	Contractwith Customer Asset Deferred Financial Institution Implementation Costs Recoveries Through Financial Institution Share Net ContractwithCustomerAssetDeferredFinancialInstitutionImplementationCostsRecoveriesThroughFinancialInstitutionShareNet	0	USD
	cdlx	Contractwith Customer Asset Deferred Financial Institution Implementation Costs Recoveries Through Financial Institution Share Net ContractwithCustomerAssetDeferredFinancialInstitutionImplementationCostsRecoveriesThroughFinancialInstitutionShareNet	2312000	USD
	cdlx	Contractwith Customer Asset Deferred Financial Institution Implementation Costs Recoveries Through Financial Institution Share Net ContractwithCustomerAssetDeferredFinancialInstitutionImplementationCostsRecoveriesThroughFinancialInstitutionShareNet	0	USD
CY2019Q2	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	-731000	USD
CY2020Q2	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	-991000	USD
	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	-1384000	USD
	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	-1999000	USD
CY2019Q2	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	12181000	USD
CY2020Q2	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	6384000	USD
CY2019Q2	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	12181000	USD
CY2020Q2	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	6384000	USD
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2019Q2	cdlx	Adjusted Contribution AdjustedContribution	21841000	USD
CY2020Q2	cdlx	Adjusted Contribution AdjustedContribution	12402000	USD
	cdlx	Adjusted Contribution AdjustedContribution	39478000	USD
	cdlx	Adjusted Contribution AdjustedContribution	32781000	USD
CY2019Q2	cdlx	Contractwith Customer Asset Deferred Implementation Costs Amortization ContractwithCustomerAssetDeferredImplementationCostsAmortization	731000	USD
CY2020Q2	cdlx	Contractwith Customer Asset Deferred Implementation Costs Amortization ContractwithCustomerAssetDeferredImplementationCostsAmortization	991000	USD
	cdlx	Contractwith Customer Asset Deferred Implementation Costs Amortization ContractwithCustomerAssetDeferredImplementationCostsAmortization	1384000	USD
	cdlx	Contractwith Customer Asset Deferred Implementation Costs Amortization ContractwithCustomerAssetDeferredImplementationCostsAmortization	1999000	USD
CY2019Q2	cdlx	Delivery Costs DeliveryCosts	3370000	USD
CY2020Q2	cdlx	Delivery Costs DeliveryCosts	3499000	USD
	cdlx	Delivery Costs DeliveryCosts	6616000	USD
	cdlx	Delivery Costs DeliveryCosts	6905000	USD
CY2019Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	11047000	USD
CY2020Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	10405000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	20384000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	21373000	USD
CY2019Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2782000	USD
CY2020Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3966000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5723000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7817000	USD
CY2019Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8340000	USD
CY2020Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11734000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	15340000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	22478000	USD
CY2019Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1053000	USD
CY2020Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1545000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2014000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3876000	USD
CY2019Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1028000	USD
CY2020Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-20000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-841000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1622000	USD
CY2019Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6510000	USD
CY2020Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-19758000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-12824000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-33289000	USD
CY2019Q2	us-gaap	Revenues Revenues	48730000	USD
CY2020Q2	us-gaap	Revenues Revenues	28222000	USD
	us-gaap	Revenues Revenues	84718000	USD
	us-gaap	Revenues Revenues	73731000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	14290000	USD
CY2020Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12983000	USD

Files In Submission

Name	View Source	Status
0001666071-20-000232-index-headers.html	Edgar Link	pending
0001666071-20-000232-index.html	Edgar Link	pending
0001666071-20-000232.txt	Edgar Link	pending
0001666071-20-000232-xbrl.zip	Edgar Link	pending
cardlytics_logoa29.jpg	Edgar Link	pending
cdlx-20200630.xsd	Edgar Link	pending
cdlx-20200630_cal.xml	Edgar Link	unprocessable
cdlx-20200630_def.xml	Edgar Link	unprocessable
cdlx-20200630_lab.xml	Edgar Link	unprocessable
cdlx-20200630_pre.xml	Edgar Link	unprocessable
cdlxform10-q2020q2.htm	Edgar Link	pending
cdlxform10-q2020q2ex101.htm	Edgar Link	pending
cdlxform10-q2020q2ex311.htm	Edgar Link	pending
cdlxform10-q2020q2ex312.htm	Edgar Link	pending
cdlxform10-q2020q2ex321.htm	Edgar Link	pending
cdlxform10-q2020q2_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CDLX
Cardlytics, Inc. Stock $cdlx

2020 Q2 Form 10-Q Financial Statement

#000166607120000232 Filed on August 04, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CDLX Cardlytics, Inc. Stock $cdlx

2020 Q2 Form 10-Q Financial Statement

#000166607120000232 Filed on August 04, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CDLX
Cardlytics, Inc. Stock $cdlx